Your browser is no longer supported. Please, upgrade your browser.
Settings
CORT Corcept Therapeutics Incorporated daily Stock Chart
CORT [NASD]
Corcept Therapeutics Incorporated
Index- P/E10.03 EPS (ttm)1.42 Insider Own0.80% Shs Outstand116.46M Perf Week0.42%
Market Cap1.66B Forward P/E13.87 EPS next Y1.03 Insider Trans35.32% Shs Float105.05M Perf Month9.05%
Income181.00M PEG- EPS next Q0.17 Inst Own77.00% Short Float15.11% Perf Quarter-13.35%
Sales216.00M P/S7.67 EPS this Y50.00% Inst Trans-0.19% Short Ratio11.80 Perf Half Y-19.34%
Book/sh2.11 P/B6.74 EPS next Y63.22% ROA69.60% Target Price16.70 Perf Year-20.91%
Cash/sh1.37 P/C10.35 EPS next 5Y-9.50% ROE80.30% 52W Range11.55 - 25.96 Perf YTD-21.26%
Dividend- P/FCF19.46 EPS past 5Y39.00% ROI85.00% 52W High-45.22% Beta1.61
Dividend %- Quick Ratio6.20 Sales past 5Y117.00% Gross Margin97.90% 52W Low23.12% ATR0.63
Employees136 Current Ratio6.40 Sales Q/Q75.00% Oper. Margin35.70% RSI (14)51.28 Volatility4.38% 4.02%
OptionableYes Debt/Eq0.00 EPS Q/Q38.80% Profit Margin68.40% Rel Volume0.67 Prev Close14.26
ShortableYes LT Debt/Eq0.00 EarningsAug 09 AMC Payout0.00% Avg Volume1.34M Price14.22
Recom2.60 SMA20-0.74% SMA502.81% SMA200-15.19% Volume897,368 Change-0.28%
Aug-10-18Reiterated Stifel Hold $20 → $11
May-31-18Downgrade Stifel Buy → Hold $20
Mar-09-18Initiated B. Riley FBR, Inc. Buy $30
Aug-31-17Initiated Stifel Buy $20
Feb-02-17Initiated Ladenburg Thalmann Buy $14
Apr-21-15Initiated FBR Capital Outperform $12
Jan-13-14Downgrade Stifel Buy → Hold
Aug-09-13Downgrade Ladenburg Thalmann Buy → Neutral $3.30
Aug-09-13Downgrade Janney Buy → Neutral
Feb-21-12Reiterated JMP Securities Mkt Outperform $9 → $11
Jan-06-10Upgrade Ladenburg Thalmann Neutral → Buy $4
Jul-17-08Initiated Rodman & Renshaw Mkt Outperform $8
Jun-21-07Upgrade Punk, Ziegel & Co Mkt Perform → Accumulate
Sep-12-18 08:52AM  Do Options Traders Know Something About Corcept (CORT) Stock We Don't? Zacks
Sep-04-18 08:03AM  Why These Fundamentals Make Corcept Therapeutics Incorporated (NASDAQ:CORT) Truly A Standout Investment Simply Wall St.
Aug-30-18 06:04PM  8 Stocks Joel Greenblatt Continues to Buy GuruFocus.com
Aug-29-18 07:35AM  Analysis: Positioning to Benefit within ShotSpotter, Frank's International N.V., Taseko Mines, Office Depot, Rudolph Technologies, and Corcept Therapeutics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +7.40%
Aug-26-18 11:55PM  Edited Transcript of CORT earnings conference call or presentation 9-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
Aug-25-18 06:01PM  Insider Buys Of The Week: Andeavor, Corcept, Portola Benzinga
Aug-24-18 07:30AM  [$$] Corcept Director Abruptly Switches to Buying Stock From Selling Barrons.com
Aug-20-18 04:57PM  3 High-Growth Stocks That Could Soar Motley Fool
Aug-10-18 12:38PM  Here's Why Corcept Therapeutics Inc. Fell as Much as 17.4% Today Motley Fool -5.15%
10:59AM  Corcept (CORT) Earnings and Revenues Miss Estimates in Q2 Zacks
08:00AM  Today's Research Reports on Trending Tickers: Puma Biotechnology and Corcept Therapeutics ACCESSWIRE
07:38AM  The Daily Biotech Pulse: Puma, CareDx Soar On Earnings, Corcept Plunges On Bottom-Line Miss Benzinga
Aug-09-18 06:30PM  Corcept Therapeutics (CORT) Misses Q2 Earnings and Revenue Estimates Zacks
05:26PM  Corcept: 2Q Earnings Snapshot Associated Press
04:05PM  Corcept Therapeutics Announces Second Quarter 2018 Financial Results and Stock Repurchase Program; Provides Clinical Update GlobeNewswire
03:00PM  Corcept Therapeutics Incorporated. to Host Earnings Call ACCESSWIRE
Aug-02-18 04:05PM  Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
Jul-27-18 07:35AM  Initiating Free Research Reports on Celgene and Three Other Biotech Equities ACCESSWIRE
Jun-29-18 09:23AM  Options Traders Expect Huge Moves in Corcept Therapeutics (CORT) Stock Zacks
08:15AM  Analysis: Positioning to Benefit within QEP Resources, Corcept Therapeutics, Buckle, Noble Energy, Windstream, and Camden Property Trust Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jun-27-18 10:04AM  How Corcept Therapeutics Incorporated (NASDAQ:CORT) Delivered A Better ROE Than Its Industry Simply Wall St.
Jun-25-18 07:05AM  Today's Free Research Reports Coverage on CorMedix and Three More Biotech Stocks ACCESSWIRE
Jun-19-18 02:05PM  Corcept Therapeutics Incorporated (NASDAQ:CORT) Has Attractive Fundamentals, Heres Why Simply Wall St.
08:20AM  Today's Research Reports on Trending Tickers: Corcept Therapeutics and CRISPR Therapeutics ACCESSWIRE
Jun-07-18 09:42AM  Corcept Therapeutics (CORT) Up 6.6% Since Earnings Report: Can It Continue? Zacks
Jun-04-18 05:30AM  Corcept Therapeutics Announces Positive Relacorilant Data at the 2018 American Society of Clinical Oncology Meeting GlobeNewswire
May-31-18 12:52PM  Corcept Therapeutics Is 'Fairly Valued,' Stifel Says In Downgrade Benzinga -6.04%
May-25-18 08:30AM  Today's Research Reports on Trending Tickers: Corcept Therapeutics and Verastem ACCESSWIRE
May-21-18 08:00AM  Today's Research Reports on Trending Tickers: Nektar Therapeutics and Corcept Therapeutics ACCESSWIRE
May-17-18 04:13PM  Gilead, BioMarin among Bay Area drug makers shamed by FDA in generics 'gaming' list American City Business Journals
07:50AM  Market Trends Toward New Normal in Agios Pharmaceuticals, Corcept Therapeutics, Prestige Brand, Virtu Financial, Eagle Pharmaceuticals, and Century Aluminum Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
May-16-18 08:30AM  Corcept Therapeutics Announces Presentations at the American Association of Clinical Endocrinologists 27th Annual Congress GlobeNewswire
May-14-18 08:40AM  Is the Options Market Predicting a Spike in Corcept Therapeutics (CORT) Stock? Zacks +5.93%
May-12-18 10:02AM  May Undervalued Stock Opportunities Simply Wall St.
May-11-18 07:46PM  Edited Transcript of CORT earnings conference call or presentation 8-May-18 9:00pm GMT Thomson Reuters StreetEvents
May-08-18 06:55PM  Corcept: 1Q Earnings Snapshot Associated Press
04:05PM  Corcept Therapeutics Announces First Quarter 2018 Financial results and Provides Corporate Update GlobeNewswire
May-01-18 04:05PM  Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
Apr-30-18 10:42AM  Corcept Therapeutics Incorporated (NASDAQ:CORT): Is It A Good Long Term Opportunity? Simply Wall St.
Apr-17-18 07:09PM  Should You Be Tempted To Buy Corcept Therapeutics Incorporated (NASDAQ:CORT) At Its Current PE Ratio? Simply Wall St.
Apr-06-18 02:23PM  10 Healthcare Stocks to Stave Off the Market Flu InvestorPlace
Mar-26-18 04:36AM  Why Is Corcept Therapeutics (CORT) Up 5.3% Since Its Last Earnings Report? Zacks
Mar-23-18 01:20PM  Edited Transcript of CORT earnings conference call or presentation 22-Feb-18 10:00pm GMT Thomson Reuters StreetEvents
Mar-15-18 05:00PM  Corcept Therapeutics Files Lawsuit Against Teva Pharmaceuticals for Infringement of Korlym Patents GlobeNewswire
Mar-12-18 12:45PM  Why Corcept Therapeutics Incorporated Lost 34% in February Motley Fool +5.20%
Mar-09-18 06:18PM  How Did Corcept Therapeutics Incorporateds (NASDAQ:CORT) 67.61% ROE Fare Against The Industry? Simply Wall St.
Mar-08-18 07:24PM  Corcept Plans Korlym Label Expansion, Pipeline in Progress Zacks
Mar-02-18 07:40AM  Wired News Sangamo Gets CTA from UK Agency for Evaluating SB-FIX for Treatment of Hemophilia B ACCESSWIRE
07:35AM  New Research: Key Drivers of Growth for Corcept Therapeutics, HubSpot, Tableau Software, Balchem, Steelcase, and Chimerix Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Feb-23-18 08:55AM  Corcept's (CORT) Earnings and Sales Meet Estimates in Q4 Zacks
Feb-22-18 06:31PM  Corcept misses 4Q profit forecasts Associated Press
04:05PM  Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial GlobeNewswire
01:00PM  Corcept Therapeutics Incorporated. to Host Earnings Call ACCESSWIRE
Feb-15-18 04:05PM  Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2017 Financial Results, Provide Corporate Update, Host Conference Call GlobeNewswire
Feb-13-18 05:12PM  Why Corcept Therapeutics Stock Gained 27.4% in January Motley Fool
Feb-07-18 07:16PM  Cramer's lightning round: Buy Target on its revamped stra... CNBC Videos
06:48PM  Cramer's lightning round: Buy Target on its revamped strategy CNBC
Feb-05-18 04:30PM  These Biotech Stocks Each Dived More Than 20% Is The Sell-Off Overdone? Investor's Business Daily -26.43%
03:40PM  Why Corcept Therapeutics Incorporated Stock Is Getting Clobbered Today Motley Fool
08:49AM  Corcept's stock tumbles after Teva submits NDA for generic Korlym MarketWatch
Feb-01-18 04:02PM  Biotech Roundup: Who's Popping On Drug, Merger, Earnings News? Investor's Business Daily +5.54%
08:30AM  Corcept Therapeutics Announces Fourth Quarter and Full-Year 2017 Preliminary Selected Financial Results; Provides 2018 Revenue Guidance GlobeNewswire
Jan-31-18 08:20AM  Todays Research Reports on Trending Tickers: Bellicum Pharmaceuticals and Corcept Therapeutics ACCESSWIRE
Jan-18-18 12:24PM  Harry Boxers four breakout stocks to watch include Universal Display MarketWatch +6.26%
Jan-10-18 05:59PM  Corcept Therapeutics Stock Has Healthy Institutional Support Investopedia
Jan-05-18 08:10AM  Analysis: Positioning to Benefit within Perry Ellis International, AutoZone, Corcept Therapeutics, LCI Industries, LegacyTexas Financial Group, and Micronet Enertec Technologies Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jan-03-18 10:03AM  Trevena Announces FDA Acceptance of Olinvo NDA, Shares Up Zacks
09:55AM  Achaogen's NDA for Plazomicin Gets Priority Review From FDA Zacks
Dec-29-17 11:45AM  ETFs with exposure to Corcept Therapeutics, Inc. : December 29, 2017 Capital Cube
09:55AM  TherapeuticsMD Submits NDA for VMS Candidate, Shares Rise Zacks
Dec-28-17 07:05PM  What Should We Expect From Corcept Therapeutics Incorporateds (NASDAQ:CORT) Earnings Over The Next Few Years? Simply Wall St.
09:45AM  Actinium Posts Positive DMC View on Lomab-B Phase III Trial Zacks
09:21AM  Horizon Pharma Gets FDA Nod for Procysbi Label Expansion Zacks
Dec-27-17 11:29AM  Insys' Cannabidiol Gets Fast Track Designation in the U.S. Zacks -6.23%
08:14AM  Why is Corcept's Stock Up More Than 150% So Far This Year? Zacks
08:11AM  Alexion's (ALXN) Soliris Label Expansion Approved in Japan Zacks
Dec-26-17 09:45AM  Merck's Diabetes Drugs Get FDA Nod as Adjunct Therapies Zacks +5.03%
09:17AM  BioMarin's (BMRN) Pegvaliase Review Period Extended by FDA Zacks
Dec-25-17 07:17AM  Corcept Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CORT-US : December 25, 2017 Capital Cube
Dec-22-17 08:30AM  Strength Seen in Corcept Therapeutics (CORT): Stock Soars 10.8% Zacks
03:00AM  Corcept Therapeutics Shows Rising Price Performance With Jump To 95 RS Rating Investor's Business Daily
Dec-21-17 05:20PM  Why Corcept Therapeutics Shares Climbed 10.8% Today Motley Fool +10.82%
04:15PM  This Biotech Stock Launched After Joining The S&P 600 SmallCap Investor's Business Daily
10:35AM  Allergan/Paratek's Acne Candidate NDA Filing Accepted by FDA Zacks
Dec-20-17 05:44PM  Interactive Brokers Group Set to Join S&P MidCap 400; Alarm.com Holdings and Corcept Therapeutics to Join S&P SmallCap 600 PR Newswire
Dec-19-17 09:53AM  Regeneron in Strategic Immuno-Oncology Collaboration With ISA Zacks
09:28AM  Alnylam/Sanofi Submit MAA in Europe for RNAi Candidate Zacks
Dec-18-17 05:52PM  Novartis (NVS) Oncology Head Strigini to Step Down by Dec. 31 Zacks
05:45PM  Radius Health to Get Third Day-180 List of Outstanding Issues Zacks
09:37AM  Spectrum Pharma Dismisses CEO, Makes Leadership Changes Zacks
Dec-13-17 05:45PM  Regeneron, Sanofi Report Positive Top Line Skin Cancer Data Zacks
03:46PM  Allergan Inks Deal to Buy Texas-Based Repros Therapeutics Zacks
01:01PM  ETFs with exposure to Corcept Therapeutics, Inc. : December 13, 2017 Capital Cube
09:40AM  Glaxo's Nucala Label Expansion Application Gets FDA Approval Zacks
Dec-12-17 05:58PM  Merck's Keytruda Gets FDA Priority Review for Rare Lymphoma Zacks
10:15AM  Spark Therapeutics Stock Plunges on Hemophilia Therapy Data Zacks
Dec-11-17 02:12PM  Lilly Reports Mixed Results from Late-Stage Cyramza Study Zacks
Dec-07-17 04:28PM  5 Health Care Stocks Gurus Are Buying GuruFocus.com
02:21PM  Roche Reports Tecentriq/Avastin Lung Cancer Study Data Zacks
Dec-06-17 02:10PM  Revance's Neuromodulator Injection Positive in Phase III Zacks
Corcept Therapeutics Incorporated, a pharmaceutical company, discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery, as well as develops CLIA-validated assay to measure FKBP5 gene expression. It is developing relacorilant that is in a Phase II trial to treat patients with Cushing's syndrome; abraxane in combination with relacorilant, which is in Phase I/II open label trial to treat solid tumors; and selective cortisol modulator CORT125281 combined with Xtandi that is in open label Phase I/II trial to treat patients with metastatic castration-resistant prostate cancer. The company is also developing CORT118335 selective cortisol modulator, which is in Phase I/II open label trial for the treatment of antipsychotic-induced weight gain and non-alcoholic steatotic hepatitis. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FISHMAN ROBERT SChief Medical OfficerSep 07Option Exercise3.518,00028,0808,000Sep 11 04:36 PM
FISHMAN ROBERT SChief Medical OfficerSep 07Sale14.578,000116,5330Sep 11 04:36 PM
BAKER G LEONARD JRDirectorAug 20Buy12.9235,681461,0952,834,793Aug 22 05:54 PM
BAKER G LEONARD JRDirectorAug 17Buy12.805,79274,1172,799,112Aug 20 06:19 PM
BAKER G LEONARD JRDirectorAug 16Buy12.49100,0001,248,7602,793,320Aug 20 06:19 PM
BAKER G LEONARD JRDirectorAug 15Buy12.4979,686994,9672,693,320Aug 16 05:51 PM
BAKER G LEONARD JRDirectorAug 14Buy12.47100,0001,247,000876,838Aug 16 05:51 PM
FISHMAN ROBERT SChief Medical OfficerAug 07Option Exercise3.518,00028,0808,000Aug 08 05:20 PM
FISHMAN ROBERT SChief Medical OfficerAug 07Sale14.158,000113,1850Aug 08 05:20 PM
FISHMAN ROBERT SChief Medical OfficerJul 06Option Exercise3.518,00028,0808,000Jul 09 07:50 PM
FISHMAN ROBERT SChief Medical OfficerJul 06Sale15.098,000120,6860Jul 09 07:50 PM
WILSON JAMES NDirectorJun 29Option Exercise2.3010,00023,00010,000Jul 02 06:44 PM
FISHMAN ROBERT SChief Medical OfficerJun 07Option Exercise3.518,00028,0808,000Jun 11 05:07 PM
FISHMAN ROBERT SChief Medical OfficerJun 07Sale18.238,000145,8260Jun 11 05:07 PM
Maduck SeanSee RemarksMay 15Option Exercise2.2410,00022,40020,024May 17 05:27 PM
BAKER G LEONARD JRDirectorMay 11Option Exercise2.2330,00066,900806,838May 15 05:30 PM
BAKER G LEONARD JRDirectorMay 11Sale16.0130,000480,312776,838May 15 05:30 PM
FISHMAN ROBERT SChief Medical OfficerMay 07Option Exercise3.518,00028,0808,000May 08 06:54 PM
FISHMAN ROBERT SChief Medical OfficerMay 07Sale17.688,000141,4280May 08 06:54 PM
FISHMAN ROBERT SChief Medical OfficerApr 06Option Exercise3.518,00028,0808,000Apr 09 05:57 PM
FISHMAN ROBERT SChief Medical OfficerApr 06Sale16.228,000129,7840Apr 09 05:57 PM
FISHMAN ROBERT SChief Medical OfficerMar 07Option Exercise3.518,00028,0808,000Mar 08 07:11 PM
GALA RENEE DDirectorMar 07Buy15.539,000139,80210,000Mar 07 08:38 PM
FISHMAN ROBERT SChief Medical OfficerMar 07Sale15.678,000125,3230Mar 08 07:11 PM
GALA RENEE DDirectorMar 06Buy15.301,00015,3001,000Mar 07 08:38 PM
FISHMAN ROBERT SChief Medical OfficerFeb 07Option Exercise3.518,00028,0808,000Feb 09 08:12 PM
FISHMAN ROBERT SChief Medical OfficerFeb 07Sale16.608,000132,7740Feb 09 08:12 PM
FISHMAN ROBERT SChief Medical OfficerJan 08Option Exercise3.518,00028,0808,000Jan 10 05:05 PM
FISHMAN ROBERT SChief Medical OfficerJan 08Sale18.678,000149,3490Jan 10 05:05 PM
FISHMAN ROBERT SChief Medical OfficerDec 08Option Exercise3.518,00028,0808,000Dec 12 05:15 PM
FISHMAN ROBERT SChief Medical OfficerDec 08Sale16.728,000133,7760Dec 12 05:15 PM
BAKER G LEONARD JRDirectorNov 13Option Exercise2.7030,00081,000806,838Nov 15 05:27 PM
BAKER G LEONARD JRDirectorNov 13Sale17.5930,000527,556776,838Nov 15 05:27 PM